Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Evelyne, Kohli"'
Les cercles de qualité médecins-pharmaciens, un mode de collaboration vertueux expérimenté en France
Publikováno v:
Actualités Pharmaceutiques. 59:43-46
S’inspirant du modele suisse, l’unite mixte de developpement professionnel continu sante de l’universite de Bourgogne a mis en place, sur neuf sites, des cercles de qualite medecins-pharmaciens sur le territoire francais. Les resultats, attendu
Publikováno v:
Vaccines, vol. 9, no. 8, pp. 883
Vaccines
Vaccines, Vol 9, Iss 883, p 883 (2021)
Vaccines
Vaccines, Vol 9, Iss 883, p 883 (2021)
Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43590811d1010b516fd7d5e27e0bf90b
https://serval.unil.ch/notice/serval:BIB_1C0CC61D746E
https://serval.unil.ch/notice/serval:BIB_1C0CC61D746E
Publikováno v:
Actualités Pharmaceutiques. 57:40-45
Resume Ces dernieres annees, de nombreux pharmaciens d’officine se sont engages dans des actions interprofessionnelles en soins de premier recours. Dans certains pays, ces dernieres ont fait l’objet d’une evaluation et sont reconnues en tant qu
Publikováno v:
Vaccines, vol. 9, no. 10, pp. 1140
Vaccines
Vaccines, Vol 9, Iss 1140, p 1140 (2021)
Vaccines
Vaccines, Vol 9, Iss 1140, p 1140 (2021)
Patients with multiple sclerosis (MS) are treated with drugs that may impact immune responses to SARS-CoV-2 vaccination. Evaluation of “prime-boost” (heterologous) vaccination regimens including a first administration of a viral vector-based vacc
Publikováno v:
Actualités Pharmaceutiques
Actualités Pharmaceutiques, Elsevier, 2017, 56 (569), pp.51-53. 〈http://www.sciencedirect.com/science/article/pii/S0515370017303038?via%3Dihub〉. 〈10.1016/j.actpha.2017.07.010〉
Actualités Pharmaceutiques, Elsevier, 2017, 56 (569), pp.51-53. 〈http://www.sciencedirect.com/science/article/pii/S0515370017303038?via%3Dihub〉. 〈10.1016/j.actpha.2017.07.010〉
International audience; Twenty-seven students from the Dijon health sciences training and research unit in the 6th year of their course and specialising in the community setting had the opportunity to undertake a study trip to meet Swiss colleagues.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f116945c79748d441bda34364fe8e1
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01680718
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01680718
Autor:
Michèle Grappin, Pascal Chavanet, Lionel Piroth, Evelyne Kohli, Marielle Buisson, Anne Golzi, Michel Duong, Henri Portier, Marie Froidure, Gilles Peytavin
Publikováno v:
HIV Clinical Trials. 5:216-223
Clinical trials have shown that therapeutic drug monitoring (TDM) of antiretrovirals (ARV) improves patient care. However, little is known about the usefulness of TDM in routine practice.We reviewed all the trough concentrations of protease inhibitor
Publikováno v:
Current medicinal chemistry. 21(2)
Glycoprotein 96 (Gp96)-peptide complexes are highly investigated for vaccines preparation, particularly in cancer therapy. Gp96, formerly called tumor rejection antigen (TRA)-1, is able to elicit an immune response that can protect mice against tumor
Autor:
Vincent Calvez, Isabelle Cohen-Codar, Philippe Colson, Laurence Morand-Joubert, Annick Ruffault, Claire Lamotte, Jacques Izopet, Martin S. King, Dale J. Kempf, Véronique Schneider, Anne-Geneviève Marcelin, Gilles Peytavin, Evelyne Kohli, Diane Descamps, Michel Segondy, Jean-Pierre Chauvin, Marie-Laure Chaix, Vincent Mackiewicz, Jacqueline Cottalorda, Anne Schmuck, Hélène Peigue-Lafeuille, Pierre Palmer, Emmanuel Guillevic, Véronique Brodard, Jacques Ritter
The development of human immunodeficiency virus (HIV) drug resistance during antiretroviral therapy can compromise the efficacy of subsequent regimens following virologic failure. Several studies have shown that changes in baseline viral genotype, co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f6f283717b5c283d529ca06648a89e
https://europepmc.org/articles/PMC1087618/
https://europepmc.org/articles/PMC1087618/